Advertisement
Advertisement
June 30, 2025
Verge Medical Acquires RoVo System for Peripheral Embolic Protection
June 30, 2025—Verge Medical announced the acquisition of the RoVo system and its temporary occlusion embolectomy (TOE) technology from 2MG Medical. The FDA-cleared RoVo system addresses the risk of distal embolization with its TOE technique during atherectomy and other peripheral interventions.
According to the company, the TOE technique temporarily blocks downstream blood flow through compression while a vacuum-activated catheter is advanced and rotated to create a vortex effect that efficiently captures and removes debris.
Verge Medical noted the acquisition expands its portfolio of targeted, setting-specific solutions for coronary and peripheral vascular interventions. Verge’s product portfolio also includes the Flash aorto-ostial angioplasty system and the Wavella specialty infusion catheter for venous therapy, noted the company.
Advertisement
Advertisement
